Skip to main content
. Author manuscript; available in PMC: 2013 Jun 3.
Published in final edited form as: J Immunol. 2010 Mar 5;184(7):3401–3407. doi: 10.4049/jimmunol.0901550

Figure 3.

Figure 3

CD47 KO DST fails to prolong skin allograft survival in preestablished WT→CD47 BM chimeras. Nine-week WT B6→CD47 KO B6 BM chimeras received no treatment (Non-DST controls) or DST from WT or CD47 KO bm1 donors at day −7, and skin grafting from WT bm1 donors at day 0. Data shown are donor skin graft survivals in the indicated groups.